How suitable is intravenous tocilizumab for the treatment of Graves' ophthalmopathy?

Authors	Maria Alejandra Mejía González, Javier Carbone
Journal	Expert review of clinical immunology (Expert Rev Clin Immunol) Vol. 17 Issue 11 Pg. 1151-1153 (11 2021) ISSN: 1744-8409 [Electronic] England
PMID	34704876 (Publication Type: Editorial)
Chemical References	Antibodies, Monoclonal, Humanized tocilizumab
Topics	Administration, Intravenous Antibodies, Monoclonal, Humanized (therapeutic use) Graves Ophthalmopathy (drug therapy) Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!